SJS Enterprises Subsidiary Commits Rs 81 Crore to Pune Plant
A subsidiary of SJS Enterprises is set to invest Rs 81 crore in a manufacturing facility in Pune, Maharashtra, according to a report by ET Manufacturing published on 11 October 2026. No further details on the specific product lines, construction timeline or appointed contractors were available at the time of reporting.
| Detail | Information |
|---|---|
| Promoter / Investor | SJS Enterprises (through a subsidiary) |
| Project Type | Manufacturing Facility |
| Location | Pune, Maharashtra |
| Investment Value | Rs 81 crore |
| Sub-sector | Drugs & Pharmaceuticals |
| Source / Date Reported | ET Manufacturing, 11 October 2026 |
Maharashtra's Position in India's Pharma Project Pipeline
The Pune investment sits within a broader Maharashtra pharma landscape that Projects India tracks across 1,793 active drugs and pharmaceuticals projects nationally, of which 167 are located in Maharashtra. While the state trails Gujarat (607 projects) and Telangana (244 projects) in volume, its project count places it fifth nationally among the states where capital investment in this sub-sector is being deployed.
Eighteen new drugs and pharmaceuticals projects have been added to the Projects India database in the last 90 days, reflecting continued momentum in the sector. Recent Maharashtra-based additions tracked by Projects India include an API and pharmaceutical products manufacturing project by Srikem Laboratories at Raigad valued at Rs 4.49 crore, and an API and API intermediates project by Aadi Rishabh Chemicals at Palghar valued at Rs 10 crore, both of which have entered the construction stage.
Stage Breakdown: Where Projects Stand Nationally
Understanding where projects sit in their lifecycle is directly relevant for suppliers and contractors timing their outreach. Across the 1,793 drugs and pharmaceuticals projects tracked by Projects India, the current stage distribution is as follows:
- Under Approvals: 638 projects — the largest single cohort, representing near-term construction opportunities once regulatory clearances are secured
- Construction Started: 362 projects — active sites where procurement and contracting activity is live
- Completed: 323 projects
- Approvals Received: 137 projects — cleared and likely moving toward construction shortly
- Hold: 137 projects
- Planning: 98 projects
The combined total of projects under approvals and approvals received — 775 in all — represents a substantial forward pipeline of potential construction and supply opportunities in the coming months. Suppliers tracking this sub-sector can consult the Industrial Projects sector overview for a broader view of capital expenditure activity.
Gujarat Dominates, but Investment Is Spread Across Six Key States
Gujarat remains the leading state for drugs and pharmaceuticals project activity with 607 tracked projects, followed by Telangana (244), Andhra Pradesh (231), Karnataka (214), Maharashtra (167) and Himachal Pradesh (59). These six states account for the bulk of tracked investment in the sub-sector. Recent project activity spans a wide range of investment sizes, from Rs 4.49 crore facility expansions to a Rs 195 crore API and intermediates project by Chromo Laboratories India in Sangareddy, Telangana, which is currently under approvals.
For context on the policy environment shaping this investment, the PLI scheme has been associated with Rs 5,210 crore in bulk drug investment by 2026, underpinning sustained capital deployment across API and formulations manufacturing.
What this means for suppliers and contractors
The Rs 81 crore Pune facility represents a mid-scale greenfield or expansion opportunity in one of Maharashtra's established industrial corridors. Civil contractors, equipment suppliers, clean-room fit-out specialists and utility providers active in the Pune region should monitor this project as it progresses through approvals and into the construction phase, at which point procurement decisions are typically made.
More broadly, the stage data above identifies 362 projects nationally that are already in active construction — representing live demand for pharma-grade equipment, raw materials and specialist contracting services right now. The 137 projects that have received approvals but not yet broken ground are the most time-sensitive targets for early engagement. Suppliers can browse all tracked projects on the Projects India platform to filter by state, stage and investment size for targeted business development.
Frequently asked questions
How much is the SJS Enterprises subsidiary investing in Pune?
A subsidiary of SJS Enterprises is reported to be investing Rs 81 crore in a manufacturing facility in Pune, Maharashtra. This was reported by ET Manufacturing on 11 October 2026. No further project details such as timeline or scope were available from the source.
How many pharmaceutical manufacturing projects are active in Maharashtra?
Projects India currently tracks 167 drugs and pharmaceuticals projects in Maharashtra, placing the state fifth nationally. Gujarat leads with 607 tracked projects, followed by Telangana, Andhra Pradesh and Karnataka.
What stage are most pharma projects in India at currently?
Of 1,793 tracked drugs and pharmaceuticals projects in India, 638 are under approvals, 362 are in active construction, and 137 have received approvals and are likely moving toward construction. Together these represent a substantial near-term pipeline.
